Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study

Umut Kirli; Tolga Binbay; Marjan Drukker; Hayriye Elbi; Bulent Kayahan; Duygu Keskin Gokcelli; Ferda Ozkinay; Huseyin Onay; Koksal Alptekin; Jim van Os

doi:10.1002/ajmg.b.32641

Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study

Umut Kirli^*, Tolga Binbay, Marjan Drukker, Hayriye Elbi, Bulent Kayahan, Duygu Keskin Gokcelli, Ferda Ozkinay, Huseyin Onay, Koksal Alptekin, Jim van Os

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	113-121
Number of pages	9
Journal	American Journal of Medical Genetics Part B-neuropsychiatric Genetics
Volume	180
Issue number	2
DOIs	https://doi.org/10.1002/ajmg.b.32641
Publication status	Published - Mar 2019

Keywords

AGE
BDNF
BDNF GENE
BIPOLAR DISORDER
CANDIDATE GENES
NEUROTROPHIC FACTOR VAL66MET
ONSET
RECEPTOR
RISK
SCHIZOPHRENIA
SYMPTOMS
environmental factors
epidemiology
extended psychosis phenotype
transdiagnostic psychosis phenotype
FACTOR GENE

Access to Document

10.1002/ajmg.b.32641

Cite this

Kirli, U., Binbay, T., Drukker, M., Elbi, H., Kayahan, B., Gokcelli, D. K., Ozkinay, F., Onay, H., Alptekin, K., & van Os, J. (2019). Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study. American Journal of Medical Genetics Part B-neuropsychiatric Genetics, 180(2), 113-121. https://doi.org/10.1002/ajmg.b.32641

Kirli, Umut ; Binbay, Tolga ; Drukker, Marjan ; Elbi, Hayriye ; Kayahan, Bulent ; Gokcelli, Duygu Keskin ; Ozkinay, Ferda ; Onay, Huseyin ; Alptekin, Koksal ; van Os, Jim. / Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study. In: American Journal of Medical Genetics Part B-neuropsychiatric Genetics. 2019 ; Vol. 180, No. 2. pp. 113-121.

@article{65e9c34368944d3c9ecffd231fe26e8a,

title = "Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study",

keywords = "AGE, BDNF, BDNF GENE, BIPOLAR DISORDER, CANDIDATE GENES, NEUROTROPHIC FACTOR VAL66MET, ONSET, RECEPTOR, RISK, SCHIZOPHRENIA, SYMPTOMS, environmental factors, epidemiology, extended psychosis phenotype, transdiagnostic psychosis phenotype, FACTOR GENE",

author = "Umut Kirli and Tolga Binbay and Marjan Drukker and Hayriye Elbi and Bulent Kayahan and Gokcelli, {Duygu Keskin} and Ferda Ozkinay and Huseyin Onay and Koksal Alptekin and {van Os}, Jim",

year = "2019",

month = mar,

doi = "10.1002/ajmg.b.32641",

language = "English",

volume = "180",

pages = "113--121",

journal = "American Journal of Medical Genetics Part B-neuropsychiatric Genetics",

issn = "1552-4841",

publisher = "Wiley",

number = "2",

}

Kirli, U, Binbay, T, Drukker, M, Elbi, H, Kayahan, B, Gokcelli, DK, Ozkinay, F, Onay, H, Alptekin, K & van Os, J 2019, 'Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study', American Journal of Medical Genetics Part B-neuropsychiatric Genetics, vol. 180, no. 2, pp. 113-121. https://doi.org/10.1002/ajmg.b.32641

Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study. / Kirli, Umut; Binbay, Tolga; Drukker, Marjan; Elbi, Hayriye; Kayahan, Bulent; Gokcelli, Duygu Keskin; Ozkinay, Ferda; Onay, Huseyin; Alptekin, Koksal; van Os, Jim.

In: American Journal of Medical Genetics Part B-neuropsychiatric Genetics, Vol. 180, No. 2, 03.2019, p. 113-121.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study

AU - Kirli, Umut

AU - Binbay, Tolga

AU - Drukker, Marjan

AU - Elbi, Hayriye

AU - Kayahan, Bulent

AU - Gokcelli, Duygu Keskin

AU - Ozkinay, Ferda

AU - Onay, Huseyin

AU - Alptekin, Koksal

AU - van Os, Jim

PY - 2019/3

Y1 - 2019/3

KW - AGE

KW - BDNF

KW - BDNF GENE

KW - BIPOLAR DISORDER

KW - CANDIDATE GENES

KW - NEUROTROPHIC FACTOR VAL66MET

KW - ONSET

KW - RECEPTOR

KW - RISK

KW - SCHIZOPHRENIA

KW - SYMPTOMS

KW - environmental factors

KW - epidemiology

KW - extended psychosis phenotype

KW - transdiagnostic psychosis phenotype

KW - FACTOR GENE

U2 - 10.1002/ajmg.b.32641

DO - 10.1002/ajmg.b.32641

M3 - Article

C2 - 29785763

VL - 180

SP - 113

EP - 121

JO - American Journal of Medical Genetics Part B-neuropsychiatric Genetics

JF - American Journal of Medical Genetics Part B-neuropsychiatric Genetics

SN - 1552-4841

IS - 2

ER -